No Data
No Data
Jinneng Science&Technology (603113.SH): Both the Qingdao Second Propylene and Polypropylene Production Line and the Qiheshan Potassium Sorbate Production Line are in the trial production stage.
Jinneng Science & Technology (603113.SH) stated on the investor interaction platform on August 12 that the Qingdao Phase II propylene and polypropylene production lines and the Qihai potassium sorbate production line are all in the trial production stage.
Jinneng Science&Technology (603113.SH) does not produce vitamin products.
Jinneng Science&Technology (603113.SH) stated on the investor platform that the company does not produce vitamin products. Acrylic is one of the raw materials in the company's products for producing methionine, which is one of the essential amino acids for the synthesis of various proteins in the human body, and it can be used for nutritional supplements and auxiliary treatments for diseases such as pneumonia, cirrhosis, and fatty liver. Methionine can be used to synthesize medicinal vitamins, nutritional supplements, fodder additives, etc.
As of August 9th, 2024, the number of shareholders in Jinneng Science & Technology (603113.SH) is 35,799.
As of August 9, 2024, Jinneng Science&Technology (603113.SH) has a total of 35,799 shareholders according to the investor interactive platform.
As of July 19, 2024, the number of shareholders of Jinneng Science&Technology (603113.SH) is 35,483.
On July 22, Gelunhui reported that as of July 19, 2024, the number of shareholders of Jinneng Science&Technology (603113.SH) was 35,483 on the investor interaction platform.
As of July 10, 2024, there are a total of 35,701 shareholders in Jinneng Science&Technology (603113.SH).
On July 11, Gelonhui reported that as of July 10, 2024, Jinneng Science&Technology has a total of 35,701 shareholders.
Jinneng Science&Technology Co., Ltd. announces earnings forecast for H1 2024.
No Data